Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761]. (December 2021) - Runfeng, Li; Yunlong, Hou; Jicheng, Huang; Weiqi, Pan; Qinhai, Ma; Yongxia, Shi; Chufang, Li; Jin, Zhao; Zhenhua, Jia; Haiming, Jiang; Kui, Zheng; Shuxiang, Huang; et al.